...
首页> 外文期刊>OncoTargets and therapy >Long Non-Coding RNA LINC00152 Regulates Cell Proliferation, Migration And Invasion In Esophageal Squamous Cell Carcinoma Via miR-107/Rab10 Axis
【24h】

Long Non-Coding RNA LINC00152 Regulates Cell Proliferation, Migration And Invasion In Esophageal Squamous Cell Carcinoma Via miR-107/Rab10 Axis

机译:长非编码RNA LINC00152通过miR-107 / Rab10轴调节食管鳞状细胞癌中的细胞增殖,迁移和侵袭

获取原文

摘要

Background: Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor in East Asia. Emerging evidence indicated that long intergenic non-coding RNA 152 (LINC00152) acts as an oncogene in many types of cancers including ESCC. This study aims to identify the biological mechanisms of LINC00152 in ESCC, hinting for new therapeutic target for ESCC patients. Methods: The levels of LINC00152, microRNA-107 (miR-107) and Ras-related protein Rab-10 (Rab10) were measured in ESCC tissues and cells using qRT-PCR. The protein level of Rab10 was measured by Western blot assay. The putative target of LINC00152 or miR-107 was searched using starBase v2.0 and TargetScan online databases, and dual-luciferase reporter assay was conducted to detect the interaction between miR-107 and LINC00152 or Rab10. The cell viability was monitored by CCK8 assay, and the abilities of migration and invasion were assessed by Transwell assay, respectively. The mice model experiments were constructed to affirm the biological role of LINC00152 in vivo. Results: LINC00152, Rab10 was significantly upregulated, and miR-107 was strikingly down-regulated in ESCC tissues and cell lines (TE-1 and KYSE30). LINC00152 was verified as a sponge for miR-107, and Rab10 was a direct target of miR-107. LINC00152 depletion decreased cell viability and abilities of migration and invasion by regulating miR-107 in vitro and blocked xenograft tumor growth in vivo. The overexpression of miR-107 reduced cell viability and the abilities of migration and invasion by modulating Rab10. LINC00152 positively regulated Rab10 expression by sponging miR-107. Conclusion: In this study, we found that LINC00152 modulated Rab10 to promote cell proliferation, migration and invasion in ESCC by sponging miR-107. This new regulatory network may provide a novel therapeutic target for ESCC patients.
机译:背景:食管鳞状细胞癌(ESCC)是东亚地区常见的恶性肿瘤。新兴证据表明,较长的基因间非编码RNA 152(LINC00152)在包括ESCC在内的许多类型的癌症中均作为癌基因。这项研究旨在确定LINC00152在ESCC中的生物学机制,为ESCC患者寻找新的治疗靶标。方法:采用qRT-PCR检测ESCC组织和细胞中LINC00152,microRNA-107(miR-107)和Ras相关蛋白Rab-10(Rab10)的水平。 Rab10的蛋白质水平通过蛋白质印迹法测定。使用starBase v2.0和TargetScan在线数据库搜索LINC00152或miR-107的推定靶标,并进行双荧光素酶报告基因检测以检测miR-107和LINC00152或Rab10之间的相互作用。通过CCK8测定法监测细胞活力,并通过Transwell测定法分别评估迁移和侵袭能力。构建小鼠模型实验以确认LINC00152在体内的生物学作用。结果:在ESCC组织和细胞系(TE-1和KYSE30)中,LINC00152,Rab10显着上调,而miR-107显着下调。 LINC00152被证实是miR-107的海绵,Rab10是miR-107的直接靶标。 LINC00152耗竭通过在体外调节miR-107降低了细胞活力以及迁移和侵袭能力,并在体内阻止了异种移植肿瘤的生长。 miR-107的过表达通过调节Rab10降低了细胞活力以及迁移和侵袭能力。 LINC00152通过使miR-107海绵化,正调控Rab10的表达。结论:在这项研究中,我们发现LINC00152通过使miR-107变海绵来调节Rab10以促进ESCC中的细胞增殖,迁移和侵袭。这个新的监管网络可能为ESCC患者提供新的治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号